Science Explorer Back to mapMap
Discussion
Company · Espoo · Finland

Zora Biosciences (Finland)

zora.fiROR OpenAlex
Research works
41
▼ 22% vs 2018-21
Citations
2.4k
57.3 per fractional work
Top-10% rate
7.7%
all institutions 10.0%
Open access
46%
world 40%
International
68%
world 18%
Zora Biosciences (Finland)

Not ranked overall: Zora Biosciences (Finland) is under the volume floor below which a citation excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Zora Biosciences (Finland) work in?

In all years, 51% of research at Zora Biosciences (Finland) is in Life Sciences, 37% in Health Sciences. Its largest fields are Biochemistry, Genetics and Molecular Biology (47%), Medicine (34%), Chemistry (8%). It does 2.6× the world's share of Life Sciences.

Life Sciences: 21 fractional works · 51.5% of its workBiochemistry, Genetics and Molecular Biology: 19 fractional works · 46.8% of its workMolecular Biology: 15 fractional works · 35.9% of its workCancer Research: 2 fractional works · 4.0% of its workBiochemistry: 2 fractional works · 3.8% of its workCell Biology: 1 fractional works · 1.4% of its workGenetics: 0 fractional works · 1.0% of its workClinical Biochemistry: 0 fractional works · 0.6% of its workImmunology and Microbiology: 1 fractional works · 2.1% of its workImmunology: 1 fractional works · 2.1% of its workAgricultural and Biological Sciences: 1 fractional works · 1.2% of its workPlant Science: 0 fractional works · 0.9% of its workSmaller subfields together: 0 fractional works · 0.3% of its workNeuroscience: 0 fractional works · 0.8% of its workEndocrine and Autonomic Systems: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.3% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 0.5% of its workPharmacology: 0 fractional works · 0.5% of its workHealth Sciences: 15 fractional works · 36.9% of its workMedicine: 14 fractional works · 33.9% of its workEndocrinology, Diabetes and Metabolism: 3 fractional works · 7.6% of its workSurgery: 3 fractional works · 6.8% of its workEpidemiology: 2 fractional works · 5.3% of its workPhysiology: 2 fractional works · 4.9% of its workCardiology and Cardiovascular Medicine: 1 fractional works · 3.6% of its workPulmonary and Respiratory Medicine: 0 fractional works · 1.0% of its workRheumatology: 0 fractional works · 0.7% of its workNephrology: 0 fractional works · 0.7% of its workInfectious Diseases: 0 fractional works · 0.5% of its workPharmacology: 0 fractional works · 0.5% of its workOncology: 0 fractional works · 0.4% of its workBiochemistry: 0 fractional works · 0.3% of its workHepatology: 0 fractional works · 0.3% of its workPathology and Forensic Medicine: 0 fractional works · 0.3% of its workRehabilitation: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.8% of its workNursing: 1 fractional works · 2.8% of its workNutrition and Dietetics: 1 fractional works · 2.8% of its workHealth Professions: 0 fractional works · 0.2% of its workPhysical Sciences: 5 fractional works · 11.3% of its workChemistry: 3 fractional works · 7.8% of its workSpectroscopy: 3 fractional works · 7.4% of its workOrganic Chemistry: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workComputer Science: 1 fractional works · 1.4% of its workComputer Networks and Communications: 0 fractional works · 0.8% of its workInformation Systems: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 0 fractional works · 1.1% of its workBiomedical Engineering: 0 fractional works · 1.0% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPhysics and Astronomy: 0 fractional works · 0.5% of its workAtomic and Molecular Physics, and Optics: 0 fractional works · 0.4% of its workSmaller subfields together: 0 fractional works · 0.1% of its workMaterials Science: 0 fractional works · 0.4% of its workPolymers and Plastics: 0 fractional works · 0.4% of its workMathematics: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.3% of its workPsychology: 0 fractional works · 0.3% of its workExperimental and Cognitive Psychology: 0 fractional works · 0.3% of its workALL ITS WORKZora Biosciences(Finland)41fractional works, all years
Life Sciences51%Physical Sciences11%Health Sciences37%Social Sciences0%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in all years. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1946.8%
    2. Immunology and Microbiology12.1%
    3. Agricultural and Biological Sciences11.2%
    4. Neuroscience00.8%
    5. Pharmacology, Toxicology and Pharmaceutics00.5%
    1. Medicine1433.9%
    2. Nursing12.8%
    3. Health Professions00.2%
    1. Chemistry37.8%
    2. Computer Science11.4%
    3. Engineering01.1%
    4. Physics and Astronomy00.5%
    5. Materials Science00.4%
    6. Mathematics00.1%
    1. Psychology00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.37× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.36× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 7.38× its world share, 0 worksImmunology and Micro…Neuroscience: 1.48× its world share, 0 worksNeuroscienceComputer Science: 1.01× its world share, 0 worksComputer SciencePhysics and Astronomy: 0.23× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.33× its world share, 0 worksHealth ProfessionsMedicine: 2.39× its world share, 3 worksMedicineNursing: 5.96× its world share, 0 worksNursingPsychology: 0.55× its world share, 0 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 7.4×. Every wedge is a field page.

All 10 fields, with their numbers
  1. Immunology and Microbiology7.38×0 works
  2. Nursing5.96×0 works
  3. Biochemistry, Genetics and Molecular Biology5.36×2 works
  4. Medicine2.39×3 works
  5. Neuroscience1.48×0 works
  6. Computer Science1.01×0 works
  7. Psychology0.55×0 works
  8. Agricultural and Biological Sciences0.37×0 works
  9. Health Professions0.33×0 works
  10. Physics and Astronomy0.23×0 works

Who are the top researchers at Zora Biosciences (Finland)?

Ranked on the quality score, Kim Ekroos, Dimple Kauhanen and Tuulia Sylvänne lead among researchers whose main affiliation is Zora Biosciences (Finland).

  1. 1 Kim Ekroos Finland · #49,195 worldwide 12k citations · 160 works
  2. 2 Dimple Kauhanen Finland · #251,480 worldwide 3.8k citations · 30 works
  3. 3 Tuulia Sylvänne Finland · #1,112,460 worldwide 1.5k citations · 17 works
  4. 4 Reini Hurme Finland · #1,121,946 worldwide 2.3k citations · 45 works
  5. 5 Helena Simolin Finland · #1,834,214 worldwide 1.3k citations · 21 works
All ranked researchers at Zora Biosciences (Finland)

What are the most cited papers from Zora Biosciences (Finland)?

The most cited paper from Zora Biosciences (Finland) is "Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry" (Christer S. Ejsing, Julio Lopes Sampaio, Vineeth Surendranath et al., 2009), with 1,140 citations. Next come "Molecular lipidomics of exosomes released by PC-3 prostate cancer cells" (773) and "Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol" (704).

Most cited papers
#PaperReleasedCitations
1 Global analysis of the yeast lipidome by quantitative shotgun mass spectrometry Christer S. Ejsing, Julio Lopes Sampaio, Vineeth Surendranath et al. · Proceedings of the National Academy of Sciences Open access 27 Jan 2009 1,140
2 Molecular lipidomics of exosomes released by PC-3 prostate cancer cells Alicia Llorente, Tore Skotland, Tuulia Sylvänne et al. · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 23 Apr 2013 773
3 Plasma ceramides predict cardiovascular death in patients with stable coronary artery disease and acute coronary syndromes beyond LDL-cholesterol Reijo Laaksonen et al. · European Heart Journal Open access 28 Apr 2016 704
4 Molecular lipid species in urinary exosomes as potential prostate cancer biomarkers Tore Skotland, Kim Ekroos, Dimple Kauhanen et al. · European Journal of Cancer 30 Nov 2016 344
5 Development and validation of a ceramide- and phospholipid-based cardiovascular risk estimation score for coronary artery disease patients Mika Hilvo et al. · European Heart Journal Open access 20 May 2019 316
All 60 most cited papers, with filters and sorting

Which keywords describe research at Zora Biosciences (Finland)?

By fractional works in all years, weighted toward what it does more of than the world: Insulin Resistance, Mass Spectrometry, Cancer, Cholesterol, Biomarkers, Genomics, Precision Medicine and Data Analysis.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Insulin Resistance11▲ 56×6 topics
  2. Mass Spectrometry8▲ 95×3 topics
  3. Cancer7▲ 11×7 topics
  4. Cholesterol6▲ 83×4 topics
  5. Biomarkers6▲ 24×7 topics
  6. Genomics6▲ 40×2 topics
  7. Precision Medicine6▲ 45×3 topics
  8. Data Analysis6▲ 42×1 topic
  9. Metabolomics6▲ 255×1 topic
  10. Cardiovascular Disease5▲ 12×12 topics
  11. Metabolic Syndrome5▲ 15×8 topics
  12. Apoptosis5▲ 31×2 topics
  13. Inflammation5▲ 5.0×21 topics
  14. Obesity5▲ 15×9 topics
  15. Sphingolipids5▲ 838×1 topic
  16. Sphingosine-1-Phosphate5▲ 838×1 topic
  17. Atherosclerosis4▲ 29×9 topics
  18. Diabetes3▲ 15×6 topics
  19. Statins3▲ 92×2 topics
  20. Proteomics3▲ 56×2 topics
  21. Glucose Metabolism3▲ 63×2 topics
  22. Metabolism3▲ 9.6×8 topics
  23. C-Reactive Protein2▲ 64×2 topics
  24. Global Prevalence2▲ 50×1 topic
  25. Hepatic Steatosis2▲ 32×2 topics
  26. Lifestyle Intervention2▲ 58×1 topic
  27. Lipid Rafts2▲ 65×2 topics
  28. Mitochondrial Dysfunction2▲ 12×5 topics
  29. Hypertension2▲ 12×6 topics
  30. Membrane Lipids2▲ 74×1 topic
  31. Membrane Proteins2▲ 24×1 topic
  32. Metabolic Regulation2▲ 15×3 topics
  33. Protein Identification2▲ 181×1 topic
  34. Quantitative Analysis2▲ 26×1 topic
  35. Tandem Mass Spectrometry2▲ 44×2 topics
  36. Brown Adipose Tissue2▲ 52×1 topic
  37. Exercise2▲ 26×2 topics
  38. Thermogenesis2▲ 52×1 topic
  39. Fatty Acid Synthase2▲ 96×1 topic
  40. Lipid Metabolism2▲ 96×1 topic

Which research topics does Zora Biosciences (Finland) publish most on?

By volume in 2022-now: Sphingolipid Metabolism and Signaling, Diabetes, Cardiovascular Risks, and Lipoproteins, Lipoproteins and Cardiovascular Health and Cloud Computing and Resource Management.

Sphingolipid Metabolism …1Sphingolipid Metabolism and Signaling: 1 fractional worksDiabetes, Cardiovascular…0Diabetes, Cardiovascular Risks, and Lipoproteins: 0 fractional worksLipoproteins and Cardiov…0Lipoproteins and Cardiovascular Health: 0 fractional worksCloud Computing and Resource Management: 0 fractional worksImmunotherapy and Immune Responses: 0 fractional worksCholesterol and Lipid Metabolism: 0 fractional worksFatty Acid Research and Health: 0 fractional worksParathyroid Disorders and Treatments: 0 fractional worksLiver Disease Diagnosis and Treatment: 0 fractional worksinterferon and immune responses: 0 fractional works
Molecular BiologyEndocrinology, Diabetes and MetabolismSurgeryInformation Systems4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Sphingolipid Metabolism and Signaling Molecular Biology 1 works
  2. 2 Diabetes, Cardiovascular Risks, and Lipoproteins Endocrinology, Diabetes and Metabolism 0 works
  3. 3 Lipoproteins and Cardiovascular Health Surgery 0 works
  4. 4 Cloud Computing and Resource Management Information Systems 0 works
  5. 5 Immunotherapy and Immune Responses Immunology 0 works
  6. 6 Cholesterol and Lipid Metabolism Surgery 0 works
  7. 7 Fatty Acid Research and Health Nutrition and Dietetics 0 works
  8. 8 Parathyroid Disorders and Treatments Nephrology 0 works
  9. 9 Liver Disease Diagnosis and Treatment Epidemiology 0 works
  10. 10 interferon and immune responses Immunology 0 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available45.8%not open54.2%

World: 40% of research is openly available.

with international co-authors68.5%domestic only31.5%

World: 18% is written across borders.

How has Zora Biosciences (Finland)'s research output changed?

Output in 2022-2025 was 22% lower than in 2018-2021.

still counting1990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Zora Biosciences (Finland) as a percentage of every work published that year, 0.000031% in 2024.

still counting0.00010%0.00020%Zora Biosciences (Finland)0.000026% in 20251990200020102020

Fractional works of Zora Biosciences (Finland) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Espoo

All research institutions in Espoo

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Zora Biosciences (Finland). Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.